[Skip to Content]
[Skip to Content Landing]
Article
October 1975

Therapeutic Effectiveness of Fluorometholone in Inflammatory Keratitis

Author Affiliations

From the Department of Ophthalmology and the Massachusetts Lions Eye Research Laboratory (Dr. Leibowitz), and the Department of Pharmacology (Dr. Kupferman), Boston University School of Medicine, Boston.

Arch Ophthalmol. 1975;93(10):1011-1014. doi:10.1001/archopht.1975.01010020793011
Abstract

• During an experimentally-induced inflammatory keratitis, we measured the ability of 0.1% fluorometholone ophthalmic suspension to reduce the numbers of polymorphonuclear leukocytes that invaded the cornea. The data demonstrate that topically administered fluorometholone is an effective therapeutic agent and that it compares favorably in anti-inflammatory activity with dexamethasone and prednisolone preparations. Comparison of our results with comparable studies of dexamethasone and prednisolone formulations indicates that 1.0% prednisolone acetate ophthalmic suspension is still the most effective corneal anti-inflammatory agent that we have investigated to date. However, the decreased potential of fluorometholone to produce secondary elevation of the intraocular pressure would appear to make it the drug of choice in situations in which maximum pharmacologic suppression of inflammation is not required and in chronic inflammatory conditions that require prolonged treatment.

×